Remote Health Monitoring Companies CoPilotIQ, Biofourmis Merge
CoPilotIQ said the merged company will allow customers to observe patients across the care continuum via one technology integration, one security audit, and simplified procurement
Read More
Why a digital front door in healthcare matters more than ever
Could healthcare organizations be doing more to open their digital front door? According to a 2024 study by HIMSS researchers, hospitals that embrace digital technology see stronger patient experience outcomes. This aligns with Experian Health’s most recent State of Patient Access (SOPA) survey, in which patients and providers agreed that patient access had improved thanks…
Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation
Axsome Therapeutics’ Auvelity expanded its label to include treating agitation in Alzheimer’s disease patients. It’s just the second FDA-approved drug for this indication, and Axsome’s pill has a safety advantage. The post Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation appeared first on MedCity News.
GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from Flagship-Founded Vesalius
Vesalius Therapeutics’ AI-based technology finds novel targets and intervention points for subgroups of patients within a common disease. A small molecule that Vesalius has been developing for a novel Parkinson’s disease target is now headed to GSK, which has licensed global rights. The post GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from…
Out-of-Pocket Pain From High-Deductible Plans Means Skimping on Care
David Garza sometimes feels as if he doesn’t have health insurance now that he pays so much to treat his Type 2 diabetes. His monthly premium payment of $435 for family coverage is roughly the same as the insurance at his previous job. But the policy at his current job carries an annual deductible of…
MedCity Pivot Podcast: Modernizing Prior Auth
[Sponsored] In this episode, MedCity News’ Arundhati Parmar chats with a pharmacy benefits leader and a virtual pharmacy operator about ways to modernize and scale prior authorization. The post MedCity Pivot Podcast: Modernizing Prior Auth appeared first on MedCity News.
Novartis Nabs First FDA Nod in Rare Kidney Disease, But Apellis Pharma Is on Its Heels
Novartis’s Fabhalta is the first FDA-approved therapy for C3 glomerulopathy. But Apellis Pharmaceuticals’ Empaveli has superior clinical data, and that drug has been submitted for FDA review in the same rare kidney disease as well as another one that does not yet have an approved therapy. The post Novartis Nabs First FDA Nod in Rare…
A structured approach for identifying disease analogs
Payers will often look to disease analogs when making pricing and coverage decisions. These disease analogs can inform the level of rebates, need for prior authorization/utilization management, and the drug’s cost sharing tier. Traditionally, however, disease analogs are selected on an ad hoc basis. In a recent JMCP paper titled “A structured approach for identifying…
Journalists Highlight Medical Neglect in ICE Detention, RFK Jr. Antidepressant Comments
KFF Health News chief Washington correspondent Julie Rovner discussed Health and Human Services Secretary Robert F. Kennedy Jr.’s position on antidepressants on WAMU’s 1A on June 10. Click here to hear Rovner on 1A. KFF Health News journalist Rae Ellen Bichell discussed, on WBUR’s Here & Now on June 10, a recent investigation that found…
AI in ERP: A Strategic Lever for Healthcare and Life Sciences Leaders
With the adoption of AI-enabled ERP systems, companies can improve operational efficiency, compliance, reliability and decision-making speed. The post AI in ERP: A Strategic Lever for Healthcare and Life Sciences Leaders appeared first on MedCity News.